PapersFlow Research Brief
Male Breast Health Studies
Research Guide
What is Male Breast Health Studies?
Male Breast Health Studies is a field in medicine and public health that examines male breast cancer and gynecomastia, including their diagnosis, treatment, epidemiology, risk factors, hormonal therapy, genetics, survival rates, and molecular subtypes, while comparing these conditions to female breast cancer.
The field encompasses 13,547 published works focused on male breast cancer and gynecomastia across various aspects such as diagnosis, treatment, and genetics. Key studies address histopathological features of the male breast and gynecomastia, as detailed in "Diagnostic Histopathology of the Breast" by Page and Anderson (1988). Research also covers seminal syndromes like Klinefelter syndrome involving gynecomastia, described in "Syndrome Characterized by Gynecomastia, Aspermatogenesis without A-Leydigism, and Increased Excretion of Follicle-Stimulating Hormone1" by Klinefelter et al. (1942).
Topic Hierarchy
Research Sub-Topics
Male Breast Cancer Epidemiology
This sub-topic investigates incidence, prevalence, and demographic patterns of male breast cancer globally. Researchers study temporal trends and geographic variations.
Genetics of Male Breast Cancer
Focuses on genetic risk factors like BRCA mutations and familial predispositions in male cases. Studies compare genetic profiles with female breast cancer.
Hormonal Risk Factors Gynecomastia
Examines endocrine imbalances causing gynecomastia across age groups, including pubertal, adult, and drug-induced forms. Research links hormones to breast tissue proliferation.
Treatment of Male Breast Cancer
Covers surgical, chemotherapeutic, and hormonal therapies tailored for male patients. Studies assess efficacy and compare outcomes to female counterparts.
Survival Outcomes Male Breast Cancer
Analyzes prognostic factors, stage-specific survival rates, and long-term outcomes post-diagnosis. Research incorporates molecular subtypes for prediction models.
Why It Matters
Male Breast Health Studies addresses gaps in knowledge about male breast cancer incidence, characteristics, stage at diagnosis, and treatment outcomes, as analyzed in a large population-based study in "Breast carcinoma in men" by Giordano et al. (2004), which examined 1,752 cases to reveal higher stage at diagnosis compared to female breast cancer. This informs clinical management strategies, including hormonal therapies, where adherence impacts survival, per studies like "Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review" by Murphy et al. (2012). Genetic insights, such as a single BRCA2 mutation linked to both male and female breast cancer in Icelandic families, as reported in "A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes" by Thorlacius et al. (1996), guide screening and risk assessment in high-risk populations. These findings support tailored public health interventions for rare male conditions, reducing mortality through early detection and fertility-preserving treatments discussed in "Preservation of Fertility in Patients with Cancer" by Jeruss and Woodruff (2009).
Reading Guide
Where to Start
"Diagnostic Histopathology of the Breast" by Page and Anderson (1988) is the starting point for beginners, as it provides foundational descriptions of male breast anatomy, gynecomastia, and common non-neoplastic conditions essential for understanding diagnosis.
Key Papers Explained
"Syndrome Characterized by Gynecomastia, Aspermatogenesis without A-Leydigism, and Increased Excretion of Follicle-Stimulating Hormone1" by Klinefelter et al. (1942) establishes the classic endocrine basis of gynecomastia, which "Diagnostic Histopathology of the Breast" by Page and Anderson (1988) builds upon histopathologically. Giordano et al. (2004) in "Breast carcinoma in men" extends this to epidemiology using 1,752 cases, while Fentiman et al. (2006) in "Male breast cancer" synthesizes treatment advances. Thorlacius et al. (1996) in "A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes" adds genetic connections across sexes.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research emphasizes genetics and hormonal therapies, with genetics highlighted by Thorlacius et al. (1996) on BRCA2, hormonal risks from Key (2002), and therapy effects from Nguyen et al. (2014); no recent preprints available indicate focus remains on established molecular subtypes, survival analysis, and adherence as in Murphy et al. (2012).
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Endogenous Sex Hormones and Breast Cancer in Postmenopausal Wo... | 2002 | JNCI Journal of the Na... | 1.8K | ✓ |
| 2 | Diagnostic Histopathology of the Breast | 1988 | Medical Entomology and... | 1.1K | ✕ |
| 3 | Syndrome Characterized by Gynecomastia, Aspermatogenesis witho... | 1942 | The Journal of Clinica... | 1.1K | ✕ |
| 4 | Adverse Effects of Androgen Deprivation Therapy and Strategies... | 2014 | European Urology | 780 | ✕ |
| 5 | Breast carcinoma in men | 2004 | Cancer | 776 | ✓ |
| 6 | Male breast cancer | 2006 | The Lancet | 728 | ✕ |
| 7 | Adherence to adjuvant hormonal therapy among breast cancer sur... | 2012 | Breast Cancer Research... | 703 | ✓ |
| 8 | Preservation of Fertility in Patients with Cancer | 2009 | New England Journal of... | 581 | ✓ |
| 9 | Eating Patterns and Risk of Colon Cancer | 1998 | American Journal of Ep... | 566 | ✕ |
| 10 | A single BRCA2 mutation in male and female breast cancer famil... | 1996 | Nature Genetics | 528 | ✕ |
Frequently Asked Questions
What histopathological features characterize the male breast and gynecomastia?
The male breast exhibits specific anatomy and developmental stages, with gynecomastia involving glandular proliferation. "Diagnostic Histopathology of the Breast" by Page and Anderson (1988) details these features alongside cysts, adenosis, fibroadenoma, and other non-neoplastic conditions. These descriptions aid in accurate diagnosis and differentiation from malignancy.
How does Klinefelter syndrome relate to gynecomastia?
Klinefelter syndrome, beginning in adolescence, features gynecomastia and hypogonadism primarily affecting tubular tissue function while sparing Leydig cells. "Syndrome Characterized by Gynecomastia, Aspermatogenesis without A-Leydigism, and Increased Excretion of Follicle-Stimulating Hormone1" by Klinefelter et al. (1942) characterizes this with increased follicle-stimulating hormone excretion. It represents a distinct endocrine disorder requiring targeted management.
What are the presenting characteristics of male breast carcinoma?
Male breast carcinoma presents at higher stages than female cases, with analysis of 1,752 patients showing patterns in incidence and treatment. "Breast carcinoma in men" by Giordano et al. (2004) fills gaps from prior small studies by detailing these features population-wide. Outcomes inform standardized care protocols.
What genetic factors link male and female breast cancer?
A single BRCA2 mutation associates with breast cancer in both male and female Icelandic families, showing varied phenotypes. "A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes" by Thorlacius et al. (1996) identifies this founder mutation. It underscores shared genetic risks across sexes.
How is fertility preserved in male cancer patients undergoing treatment?
Fertility preservation in male cancer patients involves sperm banking alongside oncologic treatments. "Preservation of Fertility in Patients with Cancer" by Jeruss and Woodruff (2009) emphasizes planning for young survivors with favorable outcomes. Emerging methods complement traditional approaches like in vitro fertilization in women.
What adverse effects arise from androgen deprivation therapy used in male breast conditions?
Androgen deprivation therapy causes adverse effects that require mitigation strategies. "Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them" by Nguyen et al. (2014) outlines these impacts relevant to hormonal management in male breast cancer. Interventions improve patient tolerance and adherence.
Open Research Questions
- ? What are the precise molecular subtypes distinguishing male from female breast cancer and their prognostic implications?
- ? How do endogenous sex hormone levels specifically influence male breast cancer risk compared to postmenopausal women?
- ? What long-term survival differences exist between male breast cancer treated with hormonal therapy and other modalities?
- ? How prevalent is BRCA2 mutation carriage in diverse male breast cancer populations beyond Icelandic families?
- ? What epidemiological risk factors uniquely drive gynecomastia across adolescent, adult, and elderly male groups?
Recent Trends
The field maintains 13,547 works with no specified 5-year growth rate; high-citation classics like Key on sex hormones (1783 citations) and Page and Anderson (1988) on histopathology (1065 citations) dominate, with no recent preprints or news signaling steady reliance on epidemiology from Giordano et al. (2004) (776 citations) and genetics from Thorlacius et al. (1996) (528 citations).
2002Research Male Breast Health Studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Male Breast Health Studies with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers